IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (297)	1/21/1997 9:37:00 PM
From: Jinping Shi	of 1762

Hi, Brad and all: An article on the Genetic Engineering News sent me to this thread. I have a question about the publc offering mentioned in Brad's post. Could you please explain it a little more. Based on my past experience, the price will up a little bit when their NDA is in, and starts to rally when FDA committe sets a meeting date. Before then, nothing will change dramatically. It is interesting to see $20 or so is the average line for the last year or so. The company's product has no price yet, so it is not easy to predict its value. But the result is interesting. Guess the current price has factored the expectation of being approved by FDA, say, in 4 months to 6 months. It is good to know you guys have been following this stock for a few years. Other than the public offering question, I wonder if any of you know which mutual funds are holding this stock? Cheers, Jinping

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next